CGTX vs AMGN: Which Stock is Better?

Side-by-side comparison of Cognition Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

CGTX

Cognition Therapeutics Inc

$1.11

AMGN

Amgen Inc

$355.30

Key Metrics Comparison

MetricCGTXAMGNWinner
Market Cap$97.40M$188.34BAMGN
P/E RatioN/A24.57AMGN
EPS (TTM)$N/A$14.22AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.8%AMGN

Analyze CGTX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGTX or AMGN a better investment?

Comparing CGTX and AMGN: Cognition Therapeutics Inc has a market cap of $97.40M while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGTX and AMGN?

CGTX (Cognition Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGTX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGTX or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for CGTX.

Which company is more profitable: CGTX or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for CGTX.

Which is the larger company: CGTX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $97.40M for CGTX.

Should I buy CGTX or AMGN in 2026?

Both CGTX and AMGN have investment merit. CGTX trades at $1.11 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGTX and AMGN stock?

Key differences: Market Cap ($97.40M vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).

Popular Stock Comparisons